Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer

05 July 2020: Clinical Research

Jie Yu ^1ABCDEF , Taobo Jin ^2BCDEF , Tianya Zhang ^2BCEF*

DOI: 10.12659/MSM.922672

Med Sci Monit 2020; 26:e922672

Table 1 The clinicopathological features of patients with breast cancer.

Variables	Group	Cases (n)
Age (years)		38
Age (years)	>65	42
Clinical stage	I/II	34
Clinical stage	III/IV	46
Differentiation level	Low	21
	Median	31
	High	28
Tumor size		33
Tumor size	>3 cm	47
Lymph node metastasis	Yes	32
Lymph node metastasis	No	48
ER	Positive	56
ER	Negative	24
PR	Positive	47
PR	Negative	33
HER-2	Positive	52
HER-2	Negative	28
ER – estrogen receptor; PR – progesterone receptor; HER-2 – human epidermal growth factor receptor 2.